Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jul;59(1):38-44.
doi: 10.1136/jnnp.59.1.38.

Multifocal motor neuropathy with conduction block: a study of 24 patients

Affiliations

Multifocal motor neuropathy with conduction block: a study of 24 patients

P Bouche et al. J Neurol Neurosurg Psychiatry. 1995 Jul.

Abstract

Twenty four patients with pure motor neuropathy are reported. The chronic motor involvement associated with fasciculations and cramps, mainly in the arms, led, in most patients, to an initial diagnosis of motor neuron disease. In some patients (nine of 24), there was no appreciable muscle atrophy. Tendon reflexes were often absent or weak. The finding of persistent multifocal conduction block confined to motor nerve fibres raises questions about the nature and the importance of this syndrome. Segmental reduction of motor conduction velocity occurred at the site of the block, but significant slowing of motor nerve conduction was not found outside this site. The response to intravenous IVIg treatment seems to be correlated with the absence of amyotrophy. Patients with little or no amyotrophy had an initial and sustained response to IVIg, and did not develop amyotrophy during the follow up study. They could be considered to have a variant of chronic inflammatory demyelinating polyneuropathy. Patients with pronounced amyotrophy independent of the disease duration did not respond as well to IVIg treatment, suggesting the existence of a distinct entity. Among the patients treated about two thirds who had an initial good response to IVIg had high or significant antiganglioside GM1 (anti-GM1) antibody titres, but there was no correlation between the high titres before treatment and long lasting response to IVIg treatment.

PubMed Disclaimer

References

    1. Muscle Nerve. 1989 Jan;12(1):26-31 - PubMed
    1. Can J Neurol Sci. 1989 May;16(2):194-7 - PubMed
    1. Neurology. 1990 Jul;40(7):1067-72 - PubMed
    1. Ann Neurol. 1990 Aug;28(2):146-56 - PubMed
    1. Neurology. 1990 Nov;40(11):1747-50 - PubMed